Supernus Pharmaceuticals (SUPN) EBITDA Margin Growth (5y) (2016 - 2025)
Supernus Pharmaceuticals (SUPN) EBITDA Margin Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Supernus Pharmaceuticals | 2.57 Bn | 2.19 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3,181.00 |
| Sep 30, 2025 | -6,754.00 |
| Jun 30, 2025 | -2,860.00 |
| Mar 31, 2025 | -3,842.00 |
| Dec 31, 2024 | -2,834.00 |
| Sep 30, 2024 | -1,565.00 |
| Jun 30, 2024 | -2,728.00 |
| Mar 31, 2024 | -3,194.00 |
| Dec 31, 2023 | -3,498.00 |
| Sep 30, 2023 | -3,110.00 |
| Jun 30, 2023 | -4,886.00 |
| Mar 31, 2023 | -3,135.00 |
| Dec 31, 2022 | -1,832.00 |
| Sep 30, 2022 | -2,865.00 |
| Jun 30, 2022 | -2,770.00 |
| Mar 31, 2022 | -2,787.00 |
| Dec 31, 2021 | -2,229.00 |
| Sep 30, 2021 | -1,296.00 |
| Jun 30, 2021 | 158.00 |
| Mar 31, 2021 | -447.00 |